Passage Bio Inc (PASG)
1.17
-0.03
(-2.50%)
USD |
NASDAQ |
Apr 19, 15:48
Passage Bio Cash from Operations (TTM): -78.26M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -78.26M |
| September 30, 2023 | -82.77M |
| June 30, 2023 | -87.00M |
| March 31, 2023 | -95.94M |
| December 31, 2022 | -118.21M |
| September 30, 2022 | -124.96M |
| June 30, 2022 | -142.62M |
| March 31, 2022 | -140.87M |
| December 31, 2021 | -126.88M |
| Date | Value |
|---|---|
| September 30, 2021 | -125.53M |
| June 30, 2021 | -102.00M |
| March 31, 2021 | -89.39M |
| December 31, 2020 | -80.52M |
| September 30, 2020 | -68.57M |
| June 30, 2020 | -62.47M |
| March 31, 2020 | -61.53M |
| December 31, 2019 | -39.90M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-142.62M
Minimum
Jun 2022
-39.90M
Maximum
Dec 2019
-95.73M
Average
-89.39M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Ampio Pharmaceuticals Inc | -8.564M |